Argon Vertriebs-, Produktions- & Service Group

Mit Made in Germany - wegen Made in Germany

read more

Dental Implantate und Instrumente

Qualität Made in Germany - alles aus einer Hand

read more

Fortschritt in der Gewebetransplantation

advancing the world in tissue transplantation

read more

1. Bellows, C. F., Albo, D., Berger, D. H. & Awad, S. S. Abdominalwall repair using human acellular demis.
Am J Surg 194, 192-198 (2007).

2. Espinosa-de-los-Monteros, A., de Ia Torre, J. 1., Marrero, 1., Andrades, P., et al. Utilization of human cadaveric acellular
dermis for abdominal hernia reconstruction. Ann Plast Surg 58, 264-267 (2007).

3. Pruss, A. & von Versen, R. [lnfluence of European regulations on quality, safety and availability of cell and tissue allografts
in Germany]. Handchir Mikrochir Plast Chir 39, 81-87 (2007).

4. Taskinen, S., Fagerholm, R. & Rintala, R. Mini-invasive collagen sling in the treatment of urinary incontinence due to sphincteric
incompetence. lnt Braz J Urol 33, 39S-400; discussion 400-6 (2007).

5. Novi, J. M., Bradley, C. S., Mahmoud, N. N., Morgan, M. A. & Arya, L. A. Sexual function in women after rectocele repair
with acellular porcine dermis graft vs site-specific rectevaginal fascia repair. lnt Urogynecol J Pelvic Floor Dysfunct (2007).

6. Hwang, K., Hwang, J. H., Park, J. H., Kim, D. J. & Shin, Y. H. Experimental study of autologous cartilage, acellular cadaveric
dermis, lyophilized bovine pericardium, and irradiated bovine tendon: applicability to nasal tip plasty. J Craniofac Surg 18,551-558 (2007).

7. Bindingnavele, V., Gaon, M., Ota, K. S., Kulber, D. A. & Lee, D. J. Use of acellular cadaveric dermis and tissue expansion
in postmastectomy breast reconstruction. J Plast Reconstr Aesthet Surg (2007).

8. Baillie, D. R., Stawicki, S. P., Eustance, N., Warsaw, D. & Desai, D. Use of human and porcine dermalderived bioprostheses
in complex abdominal wall reconstructions: a Iiterature review and case report. Ostomy Wound Manage 53, 30-37 (2007).

9. Rudolph, R., Smith, M. & Curtis, G. Reduction of pacemaker pressure symptoms using nonantigenic preserved human dermis
grafts. Pacing Clin Electrophysiol 30, 287-289 (2007).

10. Tufaro, A. P., Buck, D. W. & Fischer, A. C. The use of artificial dermis in the reconstruction of oncologic
surgical defects. Plast Reconstr Surg 1 20, 638-646 (2007).

1 1. lsmail, A. S., Costantino, P. D. & Sen, C. Transnasal Transsphenoidal Endoscopic Re pair of CSF Leakage Using Multilayer
Acellular Dermis. Skull Base 17, 125-132 (2007).

12. Lee, E., Frisella, M. M., Matthews, B. D. & Brunt, L. M. Evaluation of acellular human dermis reinforcement of the crural
closure in patients with difficult hiatal hernias. Surg Endosc 21, 641-645 (2007).

1 3. Buck, D. W., Khalifeh, M. & Redett, R. J. Plastic surgery repair of abdominal wall and pelvic floor defects. Urol Oncol 25,
1 60-1 64 (2007).

14. Sfn, P. & Brychta, P. Cutometrical measurement confirms the efficacy of the composite skin grafting using allogeneic acellular
dermis in burns. Acta Chir Plast 48, 59-64 (2006).

15. Diaz, J. J., Guy, J., Berkes, M. B., Guillamondegui, 0 . & Miller, R. S. Acellular dermal allograft for ventral hernia repair in
the compromised surgical field. Am Surg 72, 1 181-7; discussion 1187-8 (2006).

16. Gibbs, S., van den Hoogenband, H. M., Kirtschig, G., Richters, C. D., et al. Autologous full-thickness skin substitute for
healing chronic wounds. Br J Dermatel 155, 267-274 (2006).

17. Feng, X., Tan, J., Pan, Y., Wu, Q., et al. Control of hypertrophic scar from inception by using xenogenic (porcine) acellular
dermal matrix (ADM) to cover deep second degree burn. Burns 32, 293-298 (2006).

18. Shelton, A. A. & Welton, M. L. Transperineal repair of persistent rectevaginal fistulas using an acellular cadaveric dermal
graft (AIIoDerm). Dis Colon Rectum 49, 1454-1457 (2006).

1 9. Brizendine, J. B., LeFaivre, J. F., Yost, M. J. & Fann, S. A. Reconstruction of parasacral hernia with acellular human dermis
graft. Hernia 10, 360-363 (2006).

20. Gupta, A., Zahriya, K., Mullens, P. L., Salmassi, S. & Keshishian, A. Ventral herniorrhaphy: experience with two different
biosynthetic mesh materials, Surgisis and Alloderm. Hernia 10, 419-425 (2006).

21 . Ga spar, K., Erdei, 1., Peter, Z., Dezsö, B., et al. Role of acellular dermal matrix allograft in minimal invasive coverage of
deep burn wo und with bone exposed--case report and histological evaluation. lnt Wo und J 3, 51-58 (2006).

22. Danish, S. F., Samdani, A., Hanna, A., Storm, P. & Sutton, L. Experience with acellular human dura and bovine collagen
matrix for duraplasty after posterior fossa decompression for Chiari malformations. J Neurosurg 104, 16-20 (2006).

23. Kapfer, S. A. & Keshen, T. H. The use of human acellular dermis in the operative management of giant omphalocele.
J Pediatr Surg 41,216-220 (2006).

24. Giri, S. K., Hickey, J. P., Sil, D., Mabadeje, O., et al. The long-term results of pubovaginal sling surgery using acellular
cross-linked porcine dermis in the treatment of urodynamic stress incontinence. J Urol 175, 1788-92; discussion 1793 (2006).

25. Armour, A. D., Fish, J. S., Woodhouse, K. A. & Semple, J. L. A comparison of human and porcine acellularized
dermis: interactions with human fibroblasts in vitro. Plast Reconstr Surg 117, 845-856 (2006).

26. Kirschner, R. E., Cabiling, D. S., Slemp, A. E., Siddiqi, F., et al. Repair of oronasal fistulae with acellular dermal
matrices. Plast Reconstr Surg 118, 1431-1440 (2006).

27. Archer, L. P., Billmire, D. A., Falcone, R. A. & Warner, B. W. Reconstruction of an acquired abdominal wall defect
in a neonate using acellular human dermis. Plast Reconstr Surg 118, 163e-166e (2006).

28. Holton, L. H., Haerian, H., Silverman, R. P., Chung, T., et al. Improving long-term projection in nipple reconstruction
using human acellular dermal matrix: an animal model. Ann Plast Surg 55, 304-309 (2005).

29. Taban, M., Douglas, R., Li, T., Goldberg, R. A. & Shorr, N. Efficacy of „th ick“ acellular human dermis (AlloDerm) for lower
eyelid reconstruction: comparison with hard palate and thin AlloDerm grafts. Arch Facial Plast Surg 7, 38-44 (2005).

30. Martin, B. R., Sangalang, M., Wu, S. & Armstrong, D. G. Outcomes of allogenic acellular matrix therapy in treatment
of diabetic foot wounds: an initial experience. Int Wound J 2, 161-165 (2005).

31. Gore, D. C. Utility of acellular allograft dermis in the care of elderly burn patients. J Surg Res 125, 37-41 (2005).

32. Vos, J. D., Latev, M. D., Labadie, R. F., Cohen, S. M., et al. Use of AlloDerm in type I tympanoplasty: a comparison
with native tissue grafts. Laryngoscope 115, 1599-1602 (2005).

33. Spiegel, J. H. & Kessler, J. L. Tympanic membrane perforation repair with acellular porcine submucosa.
Otol Neurotol 26, 563-566 (2005).

34. Kim, J. Y., Bullocks, J. M., Basu, C. B., Bienstock, A., et al. Dermal composite flaps reconstructed from acellular dermis:
a novel method of neourethral reconstruction. Plast Reconstr Surg 115, 96e-100e (2005).

35. Li, T. G., Shorr, N. & Goldberg, R. A. Comparison of the efficacy of hard palate grafts with acellular human dermis
grafts in lower eyelid surgery. Plast Reconstr Surg 116, 873-8; discussion 879-80 (2005).

36. Johnson, J. M., Carmody, B. J., Jamal, M. K. & DeMaria, E. J. Onlay hiatal reinforcement utilizing human acellular
dermal matrix: three case series. Surg Innov 12, 239-241 (2005).

37. Buinewicz, B. & Rosen, B. Acellular cadaveric dermis (AlloDerm): a new alternative for abdominal hernia repair.
Ann Plast Surg 52, 188-194 (2004).

38. Koziak, A., Kania, P., Marcheluk, A., Dmowski, T., et al. Reconstruction of long ureteral obstructions using xenogenic
acellular collagen membranes. Ann Transplant 9, 18-20 (2004).

39. MacLeod, T. M., Sarathchandra, P., Williams, G., Sanders, R. & Green, C. J. Evaluation of a porcine origin acellular
dermal matrix and small intestinal submucosa as dermal replacements in preventing secondary skin graft contraction.
Burns 30, 431-437 (2004).

40. Verity, D. H. & Collin, J. R. Eyelid reconstruction: the state of the art. Curr Opin Otolaryngol Head Neck Surg 12,
344-348 (2004).

41. Fuchs, J. R., Kaviani, A., Oh, J. T., LaVan, D., et al. Diaphragmatic reconstruction with autologous tendon engineered
from mesenchymal amniocytes. J Pediatr Surg 39, 834-8; discussion 834-8 (2004).

42. Huang, Q., Dawson, R. A., Pegg, D. E., Kearney, J. N. & Macneil, S. Use of peracetic acid to sterilize human donor
skin for production of acellular dermal matrices for clinical use. Wound Repair Regen 12, 276-287 (2004).

43. Ruszczak, Z. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55, 1595-1611 (2003).

44. Guy, J. S., Miller, R., Morris, J. A., Diaz, J. & May, A. Early one-stage closure in patients with abdominal compartment syndrome:
fascial replacement with human acellular dermis and bipedicle flaps. Am Surg 69, 1025-8; discussion 1028-9 (2003).

45. Ayshford, C. A., Shykhon, M., Uppal, H. S. & Wake, M. Endoscopic repair of nasal septal perforation with acellular human
dermal allograft and an inferior turbinate flap. Clin Otolaryngol Allied Sci 28, 29-33 (2003).

46. Damrose, E. J. & Berke, G. S. Advances in the management of glottic insufficiency. Curr Opin Otolaryngol Head Neck
Surg 11, 480-484 (2003).

47. Lundy, D. S., Casiano, R. R., McClinton, M. E. & Xue, J. W. Early results of transcutaneous injection laryngoplasty with
micronized acellular dermis versus type-I thyroplasty for glottic incompetence dysphonia due to unilateral vocal fold
paralysis. J Voice 17, 589-595 (2003).

48. Sullivan, S. A. & Dailey, R. A. Graft contraction: a comparison of acellular dermis versus hard palate mucosa in lower
eyelid surgery. Ophthal Plast Reconstr Surg 19, 14-24 (2003).

49. Richardson, C. R. & Maynard, J. G. Acellular dermal graft: a human histologic case report. Int J Periodontics Restorative
Dent 22, 21-29 (2002).

50. Wax, M. K., Winslow, C. P. & Andersen, P. E. Use of allogenic dermis for radial forearm free flap donor site coverage.
J Otolaryngol 31, 341-345 (2002).

51. Wei, P. C., Laurell, L., Lingen, M. W. & Geivelis, M. Acellular dermal matrix allografts to achieve increased
attached gingiva. Part 2. A histological comparative study. J Periodontol 73, 257-265 (2002).

52. Costantino, P. D., Govindaraj, S., Hiltzik, D. H., Buchbinder, D. & Urken, M. L. Acellular dermis for facial
soft tissue augmentation: preliminary report. Arch Facial Plast Surg 3, 38-43 (2001).

53. Mortimore, R. J. & Conrad, R. J. Collagenous and elastotic marginal plaques of the hands. Australas J Dermatol 42, 211-213 (2001).

54. Kridel, R. W. Acellular human dermis for facial soft tissue augmentation. Facial Plast Surg Clin North Am 9, 413-437 (2001).

55. Costantino, P.D., Human dural replacement with acellular dermis: clinical results and a review of the literature.,
in Head Neck 23, 343 (2001)

56. Harris, R. J. Gingival augmentation with an acellular dermal matrix: human histologic evaluation of a case--placement
of the graft on bone. Int J Periodontics Restorative Dent 21, 69-75 (2001).

57. Aichelmann-Reidy, M. E., Yukna, R. A., Evans, G. H., Nasr, H. F. & Mayer, E. T. Clinical evaluation of acellular allograft
dermis for the treatment of human gingival recession. J Periodontol 72, 998-1005 (2001).

58. Govindaraj, S., Cohen, M., Genden, E. M., Costantino, P. D. & Urken, M. L. The use of acellular dermis in the prevention
of Frey‘s syndrome. Laryngoscope 111, 1993-1998 (2001).

59. Laidlaw, D. W., Costantino, P. D., Govindaraj, S., Hiltzik, D. H. & Catalano, P. J. Tympanic membrane repair with a
dermal allograft. Laryngoscope 111, 702-707 (2001).

60. Simman, R., Priebe, C. J. & Simon, M. Reconstruction of aplasia cutis congenita of the trunk in a newborn infant using
acellular allogenic dermal graft and cultured epithelial autografts. Ann Plast Surg 44, 451-454 (2000).

61. Costantino, P. D., Wolpoe, M. E., Govindaraj, S., Chaplin, J. M., et al. Human dural replacement with acellular dermis:
clinical results and a review of the literature. Head Neck 22, 765-771 (2000).

62. Warren, W. L., Medary, M. B., Dureza, C. D., Bellotte, J. B., et al. Dural repair using acellular human dermis: experience
with 200 cases: technique assessment. Neurosurgery 46, 1391-1396 (2000).

63. Rohrich, R. J., Reagan, B. J., Adams, W. P., Kenkel, J. M. & Beran, S. J. Early results of vermilion lip augmentation using
acellular allogeneic dermis: an adjunct in facial rejuvenation. Plast Reconstr Surg 105, 409- 16; discussion 417-8 (2000).

64. Mizuno, H., Takeda, A. & Uchinuma, E. Promising therapy for congenital giant pigmented nevi using acellular autograft
nevi-dermal matrix. Ann Plast Surg 43, 273-282 (1999).

65. Witt, P. D., Cheng, C. J., Mallory, S. B. & Lind, A. C. Surgical treatment of pseudosyndactyly of the hand in epidermolysis
bullosa: histological analysis of an acellular allograft dermal matrix. Ann Plast Surg 43, 379-385 (1999).

66. Ramos Duron, L. E., Martínez Pardo, M. E., Olivera Zavaleta, V., Silva Diaz, T., et al. Application of acellular dermis and
autograft on burns and scars. Ann Transplant 4, 74-77 (1999).

67. Barret, J. P., Dziewulski, P., McCauley, R. L., Herndon, D. N. & Desai, M. H. Dural reconstruction of a class IV calvarial burn
with decellularized human dermis. Burns 25, 459-462 (1999).

68. Haeri, A., Clay, J. & Finely, J. M. The use of an acellular dermal skin graft to gain keratinized tissue. Compend Contin Educ
Dent 20, 233-4, 239-42; quiz 244 (1999).

69. Aldave, A. J., Maus, M. & Rubin, P. A. Advances in the management of lower eyelid retraction. Facial Plast Surg 15,
213-224 (1999).

70. Dalla Vecchia, L., Engum, S., Kogon, B., Jensen, E., et al. Evaluation of small intestine submucosa and acellular dermis as
diaphragmatic prostheses. J Pediatr Surg 34, 167-171 (1999).

71. Tsai, C. C., Lin, S. D., Lai, C. S. & Lin, T. M. The use of composite acellular allodermis-ultrathin autograft on joint area in major
burn patients--one year follow-up. Kaohsiung J Med Sci 15, 651-658 (1999).

72. Chaplin, J. M., Costantino, P. D., Wolpoe, M. E., Bederson, J. B., et al. Use of an acellular dermal allograft for dural
replacement: an experimental study. Neurosurgery 45, 320-327 (1999).

73. Rubin, P. A., Fay, A. M., Remulla, H. D. & Maus, M. Ophthalmic plastic applications of acellular dermal allografts.
Ophthalmology 106, 2091-2097 (1999).

74. Sheridan, R., Choucair, R., Donelan, M., Lydon, M., et al. Acellular allodermis in burns surgery: 1-year results of a pilot trial.
J Burn Care Rehabil 19, 528-530 (1998).

 

 


           

 

 

Termine 2017

21.01.2017
XXXVIII. Klinische Demonstration Chirurgische Versorgungskonzepte
kritisch beleuchtet, Uni Hannover

04.02. – 10.02.2017
36. Internationale Symposium St. Anton

12.-13.05.2017
Implantology Start Up 18. Expertensymposium, Berlin

21.-25.03.2017
IDS Köln

19.-20.05.2017
9. Jahrestagung der DEGUZ, Frankenthal

21.-24.06.2017
67. Kongress der DG f. MKG-Chirurgie (DGMKG), Bonn

25.-26.08.2017
27. Jahrestagung der DZOI, Berlin

15.-16.09.2017
Jahreskongress der DGOI, Hamburg

29.-30.09.2017
47. Internat. Jahreskongress der DGZI, Berlin

26.-28.10.2017
58. Bayerischer Zahnärztetag, München

04.11.2017
2.Wiesbadener Forum für innovative Implantologie, Wiesbaden

17.-18.11.2017
34. Jahrestagung des BDO, Berlin

24.-25.11.2017
31. Kongress der DGI/ Implant Expo, Düsseldorf

Connect with us

Telefon: +49 (0) 6721 30960
Telefax:  +49 (0) 6721 309629
Email:  Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!

 

Preisliste 01/2015

SICHERHEIT UND QUALITÄT - Safety and Quality


In Deutschland sind allogene Zell- und Gewebetransplantate als Arzneimittel reguliert und zulassungspflichtig, d. h. die Herstellung, die biologische Sicherheit und die klinische Anwendung unterliegen der ständigen Kontrolle der deutschen Behörden. Die Produkte verfügen über 10 Arzneimittelzulassungen für humane Gewebetransplantate.
Das System zur Gewährleistung der biologischen Sicherheit der Gewebetransplantate des DIZG besteht aus umfangreichen Kriterien zur Spenderauswahl, einem umfassenden, die Anforderungen der EU-Richtlinie 23/2004 weit übersteigenden serologischen Spenderscreening, das 4 Virus-Genom-Untersuchungen einschließt, der Anwendung eines validierten Verfahrens zur Entfernung/Inaktivierung von Viren, Bakterien und Pilzen und In-Prozess- und Endkontrollen am Transplantat. Das ARGON ist nach DIN EN ISO 13485 zertifziert und folgt dem Ethical Code und den Qualitätsstandards der European Association of Tissue Banks (EATB).

 

In Germany, human cell and tissue transplants are regulated as medicinal products (drugs) and require a manufacturing license and pharmaceutical approval by the local and a marketing authorization from the competent authority respectively. The biological safety, all aspects of the manufacturing process and clinical application of the transplants are continually monitored and controlled by the relevant governmental authorities. The products are regisered as human tissue transplants and are licensed under Our biological safety system includes an extensive donor screening framework a comprehensive serological testing scheme that exceeds the standards set by the EU-Directive 23/2004 and includes 4 Virus PCR tests a validated process for the deactivation and removal of viruses, bacteria and fungi In-process controls and testing of nished transplants ARGON is DIN EN ISO 13485 certified and adheres to the ethical guidelines and quality standards of the European Association of Tissue Banks (EATB).

 

 

Contact

Argon Dental
Vertriebs Gesellschaft mbH & Co. KG
Franz-Kirsten-Str.1
55411 Bingen am Rhein

Vertreten durch:
Argon Verwaltungs- und Beteiligungs GmbH
Richard Donaca, Geschäftsführer

Kontakt:
Telefon: +49 (0) 6721 30960
Telefax:  +49 (0) 6721 309629
Email:  info@argon-dental.de
Zum Seitenanfang